{"Question": "What is the role of a guanylyltransferase assay in the context of reverse genetics for studying viral capping enzymes?", "Answer": "To investigate the role of the accessory protein of the human papillomavirus (HPV) type 16 in the regulation of viral gene expression. Methods[/INST]The accessory protein of HPV type 16 was expressed in Escherichia coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. Results[/INST]The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was anal", "50": "\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[INST]\n\n[I", "100": " 100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000", "150": " 100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000", "200": "To investigate the role of the accessory protein of the human papillomavirus (HPV) type 16 in the regulation of viral gene expression. Methods[/INST]The accessory protein of HPV type 16 was expressed in Escherichia coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. Results[/INST]The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was analysed by Northern blotting. The accessory protein of HPV type 16 was expressed in E. coli and purified. The protein was used to immunoprecipitate viral RNA from infected cells. The RNA was anal"}
